Concepedia

Samuel R. Mueting

SR

Statistics

Publications

4

Citations

147

H-Index

4

Active since

2014

Affiliations

University of Iowa(Current)

Samuel R. Mueting is an author at University of Iowa specializing in oncology, genetics, and medicine.

ORCID

Publications per year

2014–2016

4

Publications

4

TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

Pavla Brachova, Samuel R. Mueting, Matthew J. Carlson et al. · International Journal of Oncology · 2014 · 99 citations · Full text

, , +17

High-throughput proteome analysis reveals targeted TRPM8 degradation in prostate cancer

Swapna Asuthkar, Lusine Demirkhanyan, Samuel R. Mueting et al. · Oncotarget · 2016 · 21 citations · Full text

, , +17

Oncomorphic <i>TP</i>53 Mutations in Gynecologic Cancers Lose the Normal Protein:Protein Interactions with the microRNA Microprocessing Complex

Pavla Brachova, Samuel R. Mueting, Eric J. Devor et al. · Journal of Cancer Therapy · 2014 · 16 citations · Full text

, , +17

Identification of New Mutations at the PCNA Subunit Interface that Block Translesion Synthesis

Christine M. Kondratick, Elizabeth M. Boehm, Lynne M. Dieckman et al. · PLoS ONE · 2016 · 11 citations · Full text

, , +15

1–4 of 4